• OPEN AN ACCOUNT
Indian Indices
Nifty
24,812.05 -41.35
(-0.17%)
Sensex
81,444.66 -138.64
( -0.17%)
Bank Nifty
55,828.75 114.60
( 0.21%)
Nifty IT
39,030.90 -325.20
( -0.83%)
Global Indices
Nasdaq
42,232.06 -304.04
(-0.71%)
Dow Jones
6,003.06 -51.05
(-0.84%)
Hang Seng
38,827.31 290.57
(0.75%)
Nikkei 225
8,843.47 9.44
(0.11%)
Forex
USD-INR
86.03 0.31
(0.36%)
EUR-INR
99.49 0.53
(0.53%)
GBP-INR
116.80 0.48
(0.41%)
JPY-INR
0.60 0.00
(0.27%)

EQUITY - MARKET SCREENER

Aurobindo Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524804
INE406A01037
350.4569173
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AUROPHARMA
37.22
65009.89
EPS(TTM)
Face Value()
Div & Yield %
29.81
1
0
 

jm financial ltd
Aanchal Ispat reports standalone net loss of Rs 0.21 crore in the December 2024 quarter
Feb 01,2025
Net Loss of Aanchal Ispat reported to Rs 0.21 crore in the quarter ended December 2024 as against net loss of Rs 2.05 crore during the previous quarter ended December 2023. Sales rose 304.79% to Rs 33.80 crore in the quarter ended December 2024 as against Rs 8.35 crore during the previous quarter ended December 2023.

ParticularsQuarter Ended
Dec. 2024Dec. 2023% Var.
Sales33.808.35 305
OPM %-0.30-22.75 -
PBDT-0.08-1.89 96
PBT-0.21-2.05 90
NP-0.21-2.05 90